Abstract
The subunit vaccines, such as peptide vaccines, have been increasingly studied for prophylactic use or for the treatment of infectious diseases, autoimmune diseases, tumors, among others. The major challenge involving the use of vaccines, as a therapeutic strategy for tumors, is related to the tumor microenvironment, which allows cancer to escape from immune surveillance. In this way, the…